Contineum Therapeutics Inc-a (CTNM) SEC 13F Holdings (Q2 2026): Institutional Buyers & Sellers

CTNM ranks #4512 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

CTNM is a top-conviction position for Sectoral Asset Management Inc — at 8.3% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in CTNM belongs to Montanova Capital, LLC, but the position matters far more to Sectoral Asset Management Inc, who has 8.3% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

CTNM is down 10.4% today, but institutions show net buying of $63.2M this quarter — a divergence between today's price move and the underlying institutional flow.

CTNM reported a net loss of $57.6M over the trailing twelve months.

• Not yet profitable — net loss of $57.6M over the trailing twelve months
• Net income declined year over year, from -$56.9M to -$57.6M
• Operating cash flow was negative, using $55.3M in cash
• Current ratio of 27.50x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.06x equity — within a conventional range